13F HOLDINGS REPORT
Catalys Pacific, LLC
Quarter ended Q1 2024 · Filed May 14, 2024 · Accession 0001104659-24-060699
Total Value
$148.1M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 9,194,579 | $118.7M | 80.13% |
| 2 | HilleVax , Inc. | 43157M102 | 1,308,974 | $21.8M | 14.69% |
| 3 | Phathom Pharmaceuticals, Inc. | PHAT | 721,962 | $7.7M | 5.18% |